Andere talen BioHarvest Sciences Inc. Canadian Securities Exchange

Aandelen

BHSC

CA13767B1013

Vertraagde tijd Canadian Securities Exchange Andere beurzen 16:24:58 05-10-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,35 ^CAD	+6,06%		-2,94%	+46,67%

30/04	BioHarvest Sciences Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
16/04	BioHarvest Sciences Inc. Kondigt nieuwe campus aan voor CDMO voor botanische synthese en uitbreiding van de productiecapaciteit	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time	01/05
BioHarvest Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing	30/04
BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results	30/04
BioHarvest Sciences secures new state of the art 80,0000 square foot manufacturing facility	18/04
BioHarvest Sciences Inc. Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity	16/04
BioHarvest Sciences adds key hires as company looks to ramp up CDMO Services Business Unit	27/03
BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables	21/03
BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024	14/03
BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit	13/03
BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024	07/03
BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time	29/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules	26/02
BioHarvest Sciences Inc. Announces Launch of New Contract Development and Manufacturing Organization Business Unit	26/02
BioHarvest Sciences Inc. Signs First Contracts with Two Industrial Customers to Develop Complex Molecules Via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit	26/02
BioHarvest Sciences Issues Clarification to February 15, 2024 News Release Announcing Engagement with IR Firm	20/02
BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program	15/02
BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference	12/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BioHarvest Sciences Inc. Canadian Securities Exchange

Aandelen

BHSC

CA13767B1013

Andere talen

Filters